DatasetName,NCAPD2_S(1366) NCAPD2_S(1367) NCAPD2_S(1370) NCAPD2_S(1371) NCAPD2_S(596) NCAPD2_T(1331) NCAPD2_T(1386) NCAPD2_T(596),NCAPD2_S(1294) NCAPD2_S(13) NCAPD2_S(1310) NCAPD2_S(1315) NCAPD2_S(1330) NCAPD2_S(1333) NCAPD2_S(1357) NCAPD2_S(1395) NCAPD2_S(20) NCAPD2_S(33) NCAPD2_S(585) NCAPD2_S(603) NCAPD2_S(608) NCAPD2_S(684) NCAPD2_S(825) NCAPD2_T(1324) NCAPD2_T(1339) NCAPD2_T(1389) NCAPD2_T(586)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,,0.4726504477821477
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,0.461741152073315
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,,0.47541736064639784
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,0.4579955808232285
ZX2022_Control Replicate 2,,
HS2024_6_B_T3,,0.47476994212849044
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,0.4679680198911133
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,,0.4630430935145562
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,,
DB2022_Intensity L2,,
TM2022_mock.4h.C,,0.465104604310526
AST2020_anti-CD3.2,,0.4652388073797817
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,0.49368435725098997
FSO2013_Ratio M/L normalized Rep1___1,,0.4632935192591071
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,0.4572275229579353
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,0.6421935109216088,0.4828900557173565
WZ2023_Pu_010_30min,0.6225694114053946,0.48006202416681915
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,,0.4709066179005294
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,,
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,0.6207397665198207,0.46753989152649494
JJ2018_Ratio H/L normalized___1,,0.4591447285960537
ZQ2022_C2,,
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,,0.4385667958895101
AH2018_SILAC_MR_2_N,,0.4816494506056666
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,0.4642849042509638
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,,0.4670183852393959
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,,0.46447890641692485
EP2017_Pervanadate R#3 normalized log2 ratio,0.6236056773346497,0.4811534398134547
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,0.4668584622799934
RB2022_5_PostStrength,,
GF2025_P6_Sph,,
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.62166901938278,0.4781325548487527
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,0.4656680245240151
KBE2022_Log2_Ex_34_U,,
WZ2023_Pu_005_10min,0.6151087336940813,0.47652432118645544
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,0.46317019126271614
WZ2023_Pu_025_30min,0.6165073570829682,0.4759678667626819
AH2018_SILAC_MR_2_X,,0.48166332464801687
HS2024_4_PD_T2,,0.46855685372100536
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,0.46483724667428233
CR2017_Ratio Replicate 1.4,,0.4562648857537564
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,,
CR2017_Ratio Replicate 1.3,0.5843001916163894,0.44125174959660324
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,,0.45670600443409365
JJ2018_Ratio M/L normalized pP3,,0.46381644611521383
AH2018_SILAC_M_2_N,,0.4638283303201848
HS2024_7_PD_T2,,0.4752992923726998
FSO2013_Ratio H/L normalized Rep1___1,,0.4527260927428532
AH2018_LFQ_1_C,,0.47216476156569864
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,,0.47130663711497733
HS2024_3_B_N1,,0.4700578944631178
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.6252596147352344,0.47854931622389063
CK2022_11 40-1,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,,0.4633764300210731
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,,0.4587476655677772
FSO2013_Ratio H/L normalized Rep2,,0.45135273384781666
WZ2023_Pu_005_20min,0.6163328855228271,0.4799994056659783
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,,0.4628831202951143
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,0.45370675492068707
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,,0.4684146628616476
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,,0.4707802129422265
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,0.4667268792878147
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,0.4716612053772866
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,0.4640505998255094
CK2022_1 200-1,,0.46993780864165313
PG2020_Intensity Mock_10h_D,,0.46188906237396105
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,0.45348337665334865
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.6180081357794227,0.5050338614046392
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,0.45836476529921966
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,0.45917323613129923
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,0.4663549070862835
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,,0.4832350987144066
PG2020_Intensity 2h_C,,0.45098535680650337
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,,
KBE2022_Log2_Ex_8_T,,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,0.45723889209191954
RN2012_L11,,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,0.46921216047279357
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,,0.45891890643128574
CK2022_3 40-1,,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,0.46510852082300636
YA2020_Reporter_intensity_Cancer_No.5,,0.46135028011173856
HH2022_Reporter intensity 8,0.6046167383023122,
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,,0.4568899099911635
EJN2021_5_Rest_Basal,,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,0.46648191840007397
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,,0.46419983023818184
YA2020_Reporter_intensity_Normal_No.1,,0.46224631253951604
HS2024_3_B_T1,,0.47660287467509954
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,0.46282860022555367
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,0.6040365719008874,0.47292245622538315
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,,
HS2024_8_I_T3,,
CF2017_EOC 3,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,0.4648711845426269
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.6132653200291108,0.47653880742492305
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,,0.46164175708606675
KS2014_Intensity N3,,0.48426683105082297
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,,0.47371012314387
FSO2013_Ratio H/M normalized Rep2,,0.4681894348024861
RAM2015_Log2 A,,0.47490139304522966
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,,
KS2014_Intensity E15_2,,0.48112370826944995
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,,
HS2024_7_I_T1,,0.45893390057732364
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,0.47203842956150044
AH2018_SILAC_M_3_X,,0.44942632571781
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,0.46350960916623835
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,,0.4733145723434749
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,0.46587367787919093
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.6427944735961562,0.48473755067573165
HS2024_6_B_N1,,0.4782816110574467
KBE2022_Log2_Ex_27_T,,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,,0.4478123315153747
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,,
FSO2013_Ratio M/L normalized Rep2,,0.45678639496945933
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,0.6086530944536725,
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,,
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,,0.44649390590474497
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,,
DL2023_control-1,,
AR2021_ALG 10 μM,0.6035323352965863,0.49453966371224856
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,,0.45757668286987163
EJN2021_4_Rest_Ins,,
RN2012_H05,,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,,
HH2022_Reporter intensity 3,0.6248637408167891,0.46736359848045833
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,,0.4706258961423447
JW2021_After_3,,
GF2025_P8_Sph,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,,0.4634738902495227
CK2022_11 200-1,,0.469768310189141
CK2022_12 200-1,,0.46896295805662286
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,0.607511175476483,
WZ2023_Su_010_20min,0.6181481691710242,0.4775697270474362
AH2018_TMTMS2_2_N,0.6228639302811663,0.47641298575131014
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,
AH2018_TMTMS3_Pool,,0.45855396880387783
KS2014_Intensity N4,,0.484372058419106
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,0.46877650027892004
RM2024_Intensity D4-2___2,,0.46195929745158115
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,,0.4660034263389143
CK2022_14 200-1,,0.46890551263144664
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,
TM2022_mock.4h.A,,0.4684023831722536
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,,0.45368308821878073
AST2020_anti-CD3+PDL2.2,,0.4655277515981185
PG2020_Intensity Mock_10h_A,,0.4664589691698855
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,,0.4622235914226794
GF2025_P1_Adh,,
GF2025_P1_Sph,,
EJN2021_5_Ex_Basal,,
HS2024_7_I_T3,,0.45420233569407314
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.6154838001959584,0.4787585046805105
CF2017_EOC 1,,
CK2022_3 200-1,,0.46999079050635134
AH2018_LFQ_IT_3_C,,0.4644055899222705
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,0.4705758058451534
HS2024_5_B_T1,,0.4579547242587878
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,,0.46919918316039305
RB2022_6_PreStrength,,
CK2022_2 40-1,,
RB2022_1_PostSprint,,
CK2022_4 200-1,,0.4699464365765253
JW2021_Before_2,,
TM2022_S2.12h.A,,0.46591073031882296
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,0.4620865485456607
AR2021_ALG 1 μM,0.5948550674427622,0.4521641213108948
HS2024_4_B_T1,,0.46002706257059794
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,,0.47446874715089
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,,
CK2022_9 16-1,,0.464026535983314
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,,0.4690112836860895
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,,0.45892046835501077
CK2022_16 16-1,,0.46237528561831426
FS2019_db/db3,,
CK2022_15 40-1,,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.6156201463536031,0.47707603579334423
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,,0.4633691361039941
HS2024_5_PD_T3,,0.46931725543000363
AH2018_TMTMS3_3_X,,0.45692082698403386
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,,
AH2018_LFQ_M_1_N,,0.47129012648049246
KBE2022_Log2_Ex_27_U,,0.46985803503479956
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,,0.4743325246092837
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,,0.4632405829072018
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,,0.4243078138290043
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,,0.46287534753616394
RN2012_L13,,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,,
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,0.47092074446215265
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,0.4875078189350868
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,0.4698062425026581
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,,0.465905207144026
HH2022_Reporter intensity 6,0.608953243534117,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,,0.4783266366241589
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,0.6140404295760031,0.47350868851229105
GF2025_P3_Adh,,
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,0.6132755864655182,0.47200631432319046
RM2024_Intensity D0-1___2,,0.46386171060324893
LY2019_P4+,,0.47392803106000525
KBE2022_Log2_Ex_19_U,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,,0.4634727761886369
AST2020_Control,,0.46429840609092754
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,0.4630496148667626
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,,0.45711086960192554
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,,0.4630001421938501
HS2024_8_B_T2,,0.47085345084451913
AH2018_LFQ_1_X,,0.47651050178888427
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,,0.47742021782683325
HH2022_Reporter intensity 1,0.6252126076014941,0.4678823593730052
HH2022_Reporter intensity 2,0.6248250224984486,0.46766588523021385
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,0.4663577008859889
YA2020_Reporter_intensity_Normal_No.5,,0.462705852920063
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,0.47930285148763174
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.6027825048523394,0.45176273546714496
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,0.5929857101905057,0.4659933145818832
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,,0.4669499053865989
AR2021_KD 72h,,0.48338201400553665
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,,0.46822817625900914
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,,0.4599187072207733
KBE2022_Log2_Ex_9_U,,0.46804166295553634
AH2018_SILAC_M_3_N,,0.457332551562104
KBE2022_Log2_Ex_13_T,,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,,
CF2017_OSE 29,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,0.5804155996911404,
HS2024_7_B_N2,,0.496610465268128
PG2020_Intensity 10h_A,,
RN2012_L12,,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,,0.4669824698240389
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,,0.4746825383236439
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,,
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,
TM2022_S2.12h.B,,0.4658807376231399
RN2012_L15,,0.46158830164679815
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,0.46884003689084264
PG2020_Intensity 4h_A,,0.4467440356322583
FSO2013_Ratio H/M normalized Rep2___2,,0.46475891316758794
TM2022_mock.4h.B,,0.4660727157272381
KBE2022_Log2_Ex_24_U,,
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,,0.4773008943151184
RB2022_1_PreSprint,,
HS2024_4_I_N1,,0.4645399515189625
CK2022_7 200-1,,0.469488571411914
CK2022_5 200-1,,0.4695873926906306
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,,0.45151833953896525
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,,0.4778414468595414
AH2018_SILAC_MR_1_X,,0.47778566912925974
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,0.4650207443280345
RM2024_Intensity D4-1,,0.4650669846377037
KBE2022_Log2_Ex_25_U,,
AH2018_SILAC_3_C,,0.4669904720789058
EJN2021_5_Rest_Ins,,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,,0.47374507206049477
CK2022_4 16-1,,0.46356250653352227
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,,0.4661194199259454
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,0.6315547879048905,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,,
FSO2013_Ratio H/L normalized Rep3,,0.46056692495178575
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,0.45348314591167405
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,0.4748065609740024
KBE2022_Log2_Ex_9_T,,0.46648513513165285
AH2018_SILAC_IT_2_N,,0.4498200820426334
AH2018_SILAC_IT_1_X,,0.4644205735145806
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,0.4660536291915886
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,,
WZ2023_Pe_025_20min,0.6199067756909118,0.4796103581532513
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,,0.47652297500808277
HS2024_4_I_N2,,0.4623225505421522
AH2018_TMTMS2_3_N,0.6248465036262016,0.4732830276636484
RN2012_H06,,0.4716143782668805
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,0.4916086785868668
WZ2023_Su_005_30min,0.6277262591798303,0.47883824773524036
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.6100713130835547,0.49158924122391423
WZ2023_Su_025_10min,0.6203574864671022,0.47744256255979317
AH2018_LFQ_IT_4_X,,0.45667046135976147
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.6241815452051851,0.4787247730323941
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,0.6263830752196593,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,0.4594363884917115
EP2017_Pervanadate R#1 log2 ratio,0.6214302830599548,0.4604549466426269
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,,0.48456287158289896
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,,
LY2019_P7+,,0.46689299214937574
EP2017_Untreated R#1 normalized log2 ratio,0.5875094703361727,0.45658962530574554
RN2012_L10,,
PG2020_Intensity 4h_C,,0.4554176175325294
EP2017_Mitotic R#3 normalized log2 ratio,0.6203251511396449,0.5030736924141411
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,,
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,,0.46351307957647125
HS2024_4_B_T3,,0.4735827661195089
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,0.45238254801733824
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,,0.4742234912465182
KBE2022_Log2_Ex_6_U,,0.473291216979083
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,,0.4629877537568728
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,,0.4691874388257098
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.6167733888091743,0.5028144315463983
GF2025_P9_Sph,,
CK2022_6 200-1,,0.4697162133720898
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,,0.46254329346099293
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,,0.4685599566054972
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,0.4792209405602495
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,0.4686374934730708
HS2024_3_B_T3,,0.4685990998881277
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,0.47360541003423545
PG2020_Intensity 2h_D,,0.42743867456689383
EP2017_Untreated R#3 normalized log2 ratio,0.5799060006904236,0.4850710650714607
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,,0.46966095213622927
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,,0.453972401878709
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,0.4641081936887831
JJ2018_Ratio H/L normalized pP1,,0.4582581611551576
EP2017_Pervanadate R#2 normalized log2 ratio,0.6222679679725751,0.4709394363169758
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,0.45844258384386793
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,,0.46440734263223205
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,0.4813285503855928
KBE2022_Log2_Ex_29_T,,0.46549019340564896
HS2024_7_I_T2,,0.47114624309775077
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,0.47838507474429315
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,,
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,,0.48433141526527573
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,0.47229770063638393
PG2020_Intensity CT_C,,0.4313042131556957
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,,0.4727417942937124
EP2017_Untreated R#3 log2 ratio,0.5803669858888136,0.4871598951834098
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,,0.45471583873487553
HS2024_8_PD_T2,,
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,0.46085804107527933
HS2024_8_B_N1,,0.46847923822318754
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,,0.4723380656098041
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,0.5848797426259453,0.45381527144715134
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,,
YA2020_Reporter_intensity_Normal_No.2,,0.46129440648682724
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,0.4756730792026376
HS2024_3_PD_T3,,0.4635239259027109
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,,0.47334581898672634
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,,0.45766056728313675
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,
CK2022_2 16-1,,0.46342322910648126
RAM2015_Log2 B,,0.452005547297853
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,0.47466194283167834
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,0.47989421275160954
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,0.4602161104386515
HS2024_7_PD_T3,,0.4859584288183203
PG2020_Intensity Mock_10h_B,,
WZ2023_Su_025_30min,0.6224963916166726,0.4781596471334081
AH2018_LFQ_4_N,,0.4717187898532269
CR2017_Ratio Replicate 1.2,0.5909188020474796,0.45677892469781556
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,,0.45316560376968995
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,0.6077641322751939,
AH2018_SILAC_M_1_X,,0.46920966355853366
RB2022_7_PreEndurance,,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,0.46166033225487046
LY2019_P6+,,0.47022250832375584
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,,0.4599745254444503
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,,0.4759210608772695
RM2024_Intensity D0-1,,0.46327385980988833
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,,
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,0.46669563811388304
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,0.4696762508356646
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,,0.46637946550547293
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,,
AH2018_LFQ_2_X,,0.4738781699887711
PG2020_Intensity 2h_B,,0.4419555126204136
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,,0.4654327656482635
GF2025_P3_Sph,,
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,,0.4754178097174911
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,,0.4598493106495563
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,,0.4551486825193761
CR2017_Ratio Replicate 2.4,,0.4451856190991256
ZQ2022_N1,,
LY2019_P6-,,0.46742390790466576
RM2024_Intensity D2-3,,0.46189866889527936
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,0.4697091631699987
AH2018_LFQ_3_N,,0.4779581990602123
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,0.4729485063197002
CK2022_7 40-1,,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,,0.44262111829859035
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,0.4596078561033699
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,,0.46523810137368027
WZ2023_Su_025_20min,0.6159156226765172,0.47705447110756155
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,0.460108724311265
LY2019_P8-,,0.46876836880541317
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,,0.4498720871018232
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,
PG2020_Intensity 10h_D,,
RB2022_8_PreEndurance,,
HS2024_3_B_N2,,0.47275664059918515
EJN2021_4_Ex_Ins,,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,
EP2017_Pervanadate R#3 log2 ratio,0.6241335342241665,0.48269352125428755
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,,0.46646985565847987
AH2018_LFQ_M_4_C,,0.4508186342554251
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,,
CK2022_6 40-1,,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,,0.4722317665868375
LY2019_P3-,,0.46713709580314994
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.6201204839986745,0.47879904462899
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,,
AST2020_Control.1,,0.46546778015588824
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,,0.45879996710593873
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.6248886687834967,0.4796759140184644
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,,
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,0.46492993065946103
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.619097539444015,0.4728708994976809
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,,0.45950070308600754
HS2024_8_I_N2,,0.4573254250322397
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,,0.47719436283047945
LY2019_P8+,,0.46163500089664267
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,,0.449689669040202
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,,0.4732652795065913
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,,
LY2019_P2-,,0.4683458745320806
AH2018_LFQ_IT_1_X,,0.4682333758827579
JJ2018_Ratio H/L normalized pP3___1,,0.47300239459086835
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.6211606429442976,0.4808372237555762
AST2020_Control.2,,0.4651222529549647
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,0.46975093998740425
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,,
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,0.4641304914172556
HS2024_5_B_T2,,0.45632360345443257
HS2024_6_I_T1,,0.4587637633972857
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,,0.46727511375800196
KBE2022_Log2_Ex_36_U,,0.4674256823544082
AH2018_TMTMS3_3_N,,0.44917139772280984
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,,0.47299185465945265
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.6226954897187856,0.5086632338206298
KBE2022_Log2_Ex_36_T,,0.46766850157469525
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.6177954327904318,0.47889483005282235
KS2014_Intensity C2,,0.4827054428742685
FSO2013_Ratio H/L normalized Rep1___2,,0.4641734992088519
RM2024_Intensity D2-2,,0.46361328445182015
KBE2022_Log2_Ex_42_T,,0.4740596035910613
CK2022_9 200-1,,0.46974032450847364
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,,0.46974588225707714
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,0.45379889886032426
RBK2021_1332T Late,,
LY2019_P1-,,0.47234809961671875
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,,0.4538552350403153
HS2024_3_I_T3,,0.4760033366220422
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,,0.4762897710491457
ZQ2022_C3,,
EJN2021_3_Rest_Ins,,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,,0.47184995065028046
FSO2013_Ratio H/M normalized Rep3___2,,0.46624394001461467
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.5877486619509924,0.4582022092297676
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.6250644148751837,0.4779869290026393
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,,
KS2014_Intensity N1,,0.47835841778491484
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,0.4657279044758809
CR2017_Ratio Replicate 1,,0.4751997492253591
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,0.4746971755385001
AH2018_SILAC_MR_2_C,,0.4801302457221737
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,,0.4791949032652308
JJ2018_Ratio H/M normalized___1,,0.4750699985564297
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,
HS2024_5_B_N2,,0.4739114411490199
HS2024_5_I_N1,,0.4719263386044983
HS2024_6_I_N1,,0.4532110764011332
AR2021_KD 48h,,0.48961443708167707
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,,0.46470445239122266
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.621000497573372,0.4814327953405282
KBE2022_Log2_Ex_29_U,,
HS2024_7_B_T1,,0.4586851809460236
AH2018_LFQ_M_2_X,,0.46600600726246016
AH2018_LFQ_IT_4_N,,0.4642065826678559
CK2022_15 200-1,,0.4691143790272307
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,0.47510015388678495
JJ2018_Ratio M/L normalized pP3___1,,0.4638419224028135
KBE2022_Log2_Ex_34_T,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,,0.4725253815628332
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,,0.46994674489831756
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.6232644816689797,0.4797115011199044
RN2012_H01,,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,0.4661312545286967
EP2017_Pervanadate R#1 normalized log2 ratio,0.6210312717016496,0.45891839252768535
HS2024_8_B_T3,,0.47802549987231274
YA2020_Reporter_intensity_Cancer_No.3,,0.4611515149623518
KBE2022_Log2_Ex_44_U,,
WZ2023_Pe_010_20min,0.6169451902505033,0.48198446584858906
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,
KS2014_Intensity C1,,0.4808200155628283
FSO2013_Ratio H/M normalized Rep3___1,,0.46704982612068785
AH2018_SILAC_M_3_C,,0.45747906337567174
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,,0.46470722749030624
AH2018_SILAC_M_2_X,,0.4631155890908213
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,,0.4729726785586614
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.6268152854871417,0.4766532059992823
PG2020_Intensity 6h_C,,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,0.45449068977653356
AH2018_LFQ_M_3_N,,0.46537749849512294
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.6190534842788082,0.47385022290566453
CK2022_15 16-1,,0.462651430436625
CK2022_3 16-1,,0.4638103819355657
LY2019_P4-,,0.47010988075483945
FSO2013_Ratio H/L normalized Rep3___2,,0.464752921526616
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,,0.4708058519256784
GF2025_P8_Adh,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,0.46326496376609844
GF2025_P5_Sph,,
CK2022_10 16-1,,0.46260335431888144
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,0.46156536100977835
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.6185685518534637,0.5080105285165242
EJN2021_2_Ex_Basal,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,,0.46698385417942145
AR2021_L41 10 μM,0.6178547780817368,0.46245220229668055
CF2017_EOC 2,,
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,,0.4737078754777679
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,0.47194913947865574
CK2022_6 16-1,,0.46207718985576823
ZX2022_CB treated Replicate 1,,
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,0.4658561603570907
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,0.6249008294884849,
RM2024_Intensity D2-2___2,,0.46334033215511367
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.6333494121315766,0.47010531934239946
AR2021_L41 1 μM,,0.4575957623193959
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.6242380160926242,0.4753387796347005
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,,
KS2014_Intensity C4,,0.46834476043494916
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,,0.46790086150738935
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,,0.4579247717010282
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,,0.46700684718533864
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,,0.46144252740958863
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,,0.4674545267763431
WZ2023_Pu_025_10min,0.6085516120516021,0.47638532437901315
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,,0.472498938476749
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,,
JJ2018_Ratio H/L normalized pP1___1,,0.4564051540205245
WZ2023_Pe_010_30min,0.6276897333242287,0.4813209507539293
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,,0.4634663377374693
KS2014_Intensity C6,,0.46113919542526804
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,,
JJ2018_Ratio H/M normalized pP1,,0.46735119311192813
CK2022_16 40-1,,
AH2018_SILAC_IT_2_C,,0.46214477223934847
CK2022_5 40-1,,
AH2018_LFQ_3_X,,0.47918554965353816
UK2020_UA_3,,
LY2019_P7-,,0.4695620202942837
GF2025_P5_Adh,,
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,0.46083326017507925
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,0.5791630351481569,0.45693053120426425
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,,0.46206081786109915
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,0.644352795507452,0.47248639984020846
PG2020_Intensity CT_B,,0.461346314691992
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,,0.4779343428628776
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,
AH2018_LFQ_3_C,,0.4716893973198822
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,,0.47232327516545763
YA2020_Reporter_intensity_Cancer_No.4,,0.46100632673781045
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,,
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,0.45313074636820305
FR2021_Intensity.H,,
CK2022_14 16-1,,0.4630454262218002
AST2020_anti-CD3+PDL2,,0.4650756489941937
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,0.46848741456572895
HS2024_8_I_T1,,0.462886972431786
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.6199174195758762,0.49358462406905756
AH2018_TMTMS2_1_X,0.6254162379895891,0.469390165468145
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,
HS2024_6_I_N2,,0.47583907447032353
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,0.46561452401826137
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,,0.468770932567487
HS2024_4_I_T3,,0.4745140322892109
AH2018_SILAC_1_X,,0.4682006790801027
PG2020_Intensity 10h_B,,
AH2018_TMTMS3_1_X,,0.4562103293387323
CF2017_FTE 14,,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,,
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,,
EP2017_Untreated R#2 normalized log2 ratio,0.6022115925133488,0.4505917358701496
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,,0.47108559901493513
HS2024_5_I_N2,,0.45861693381676455
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,0.6228092888430528,0.47281685733947265
AS2011_Ratio H/L Normalized RNAi_2_1,,
